Background and ScopeMechanical thrombectomy has revolutionized the management of acute ischemic stroke (AIS), especially in ...

AngioDynamics Inc (ANGO) reports a 12% revenue increase, driven by Med Tech growth, while navigating tariff impacts and cash ...

A pulmonary thrombectomy is a procedure that removes blood clots from the lungs in order to restore blood flow, according to TriStar.

AngioDynamics remains a Buy, trading at a steep discount to peers despite double-digit MedTech growth and improving margins.

Liberate AI, an interdisciplinary project uniting researchers from the medical domain, computer science, and trustworthy AI, aims to develop an AI model capable of supporting doctors in the treatment ...

The news release detailing AngioDynamics' fiscal 2026 first quarter results crossed the wire earlier this morning and is available on the company's website. This conference call is also being ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Penumbra, Inc. is one of them. Penumbra, Inc. (NYSE:PEN) based in California, is a global leader in ...

Canaccord now projects that AngioDynamics will post revenue of $310.9 million in fiscal year 2026 and $325.1 million in ...

Most Americans have endured the annoyance of having their health insurance denied, frequently with no resolution even after ...

Background Aortogenic stroke is an important subtype of embolic strokes, yet lacks a diagnostic method for proactive ...

AngioDynamics posts narrower-than-expected Q1 loss, 12% revenue growth and margin gains; it also raises FY26 sales outlook, ...

Racial and ethnic disparities in United States stroke care vary by intervention type at the national and state levels.